Antibodies News and Research

RSS
Detection of unreported infections based on SARS-CoV-2 antibody seroprevalence

Detection of unreported infections based on SARS-CoV-2 antibody seroprevalence

12 Dec 2022
Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

Immunogenicity of SARS-CoV-2 antibody response in immune naïve children and adults

12 Dec 2022
XBB Omicron variant evades vaccine-induced immunity

XBB Omicron variant evades vaccine-induced immunity

12 Dec 2022
Novel drug shows early potential in combating multiple myeloma

Novel drug shows early potential in combating multiple myeloma

12 Dec 2022
Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

12 Dec 2022
Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

Study shows emerging Omicron sublineages efficiently evade neutralization independent of immunization history

12 Dec 2022
Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

12 Dec 2022
Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

Intranasal recombinant MVA-based vaccines effective against SARS-CoV-2 variants in mice

11 Dec 2022
How convergent evolution is creating new COVID-19 waves

How convergent evolution is creating new COVID-19 waves

11 Dec 2022
HIV-positive people are protected by Covid vaccines

HIV-positive people are protected by Covid vaccines

9 Dec 2022
What is the association between farnesoid X receptor inhibition and protection against COVID-19?

What is the association between farnesoid X receptor inhibition and protection against COVID-19?

9 Dec 2022
Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

Multi-stage HIV vaccine regimen shows promising results in Phase 1 clinical trial

8 Dec 2022
Antibodies against gentamicin associated with increased risk of type 1 diabetes in children

Antibodies against gentamicin associated with increased risk of type 1 diabetes in children

8 Dec 2022
Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

Research explores cell receptors for bat viruses to understand emergence of zoonotic diseases

8 Dec 2022
The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein

From The Native Antigen Company 8 Dec 2022
Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

8 Dec 2022
Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

8 Dec 2022
Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

7 Dec 2022
Vaccination against E. coli could help prevent some forms of childhood malnutrition, stunting

Vaccination against E. coli could help prevent some forms of childhood malnutrition, stunting

7 Dec 2022
UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

7 Dec 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback